ALLERGAN | DIRECT Trademark

Trademark Overview

On Tuesday, September 16, 2014, a trademark application was filed for ALLERGAN | DIRECT with the United States Patent and Trademark Office. The USPTO has given the ALLERGAN | DIRECT trademark a serial number of 86396030. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, January 17, 2026. This trademark is owned by Allergan, Inc.. The ALLERGAN | DIRECT trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Online retail store services featuring pharmaceutical products

Providing a website for consumers to pay current invoices
allergan | direct

General Information

Serial Number86396030
Word MarkALLERGAN | DIRECT
Filing DateTuesday, September 16, 2014
Status800 - REGISTERED AND RENEWED
Status DateSaturday, January 17, 2026
Registration Number4847456
Registration DateTuesday, November 3, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesOnline retail store services featuring pharmaceutical products
Description of MarkThe mark consists of the words "ALLERGAN" and "DIRECT" separated by a line. On the "D" in "DIRECT", there is an arrow that looks like a play button centered in the middle of the straight line on the "D" that is pointing to the right.
Goods and ServicesProviding a website for consumers to pay current invoices
NOT AVAILABLE"DIRECT"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, September 23, 2014
Primary Code035
First Use Anywhere DateWednesday, April 1, 2015
First Use In Commerce DateWednesday, April 1, 2015
International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 10, 2015
Primary Code036
First Use Anywhere DateWednesday, April 1, 2015
First Use In Commerce DateWednesday, April 1, 2015

Trademark Owner History

Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Tuesday, September 23, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 24, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 30, 2014ASSIGNED TO EXAMINER
Tuesday, December 30, 2014NON-FINAL ACTION WRITTEN
Tuesday, December 30, 2014NON-FINAL ACTION E-MAILED
Tuesday, December 30, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 9, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 10, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 18, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 9, 2015ASSIGNED TO LIE
Saturday, March 14, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 22, 2015TEAS STATEMENT OF USE RECEIVED
Saturday, September 26, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 22, 2015USE AMENDMENT FILED
Saturday, September 26, 2015STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 30, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 1, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 3, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, November 3, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 2, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 12, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 13, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, April 13, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, November 3, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, October 9, 2025TEAS SECTION 8 & 9 RECEIVED
Friday, January 16, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, January 17, 2026REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, January 17, 2026REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, January 17, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

direct allergan website providing consumers current invoices products pharmaceutical retail store services